media-49-Sema4-launches-new-genomic-testing-and-digital-tools-for-use-in-oncology

SEMA4 PRESS RELEASE | 05.30.19

Sema4 Launches New Genomic Testing and Digital Tools for Use in Oncology

Sema4, a patient-centered health intelligence company, today announced the launch of several new genomic testing services and digital tools to help oncologists deliver on the promise of precision medicine. Together, these products provide a comprehensive approach that can be used throughout a patient’s journey, from assessing risk to analyzing cancer and monitoring in remission. Demonstrations of the products will be available at Sema4’s booth (#7140) at the American Society for Clinical Oncology 2019 Annual Meeting taking place in Chicago from May 31 to June 4.